Market Place
Sourcing Support
FDA approvals rise 49% in 2023; CRISPR’s gene editing therapy sees light of day
In 2022, when the
US Food and Drug Administration (FDA) was reeling under the impact of the
pandem
FDA’s drug approvals drop 26% due to Covid; okays three costly gene therapies in H2
The year 2022 saw the lowest number of drug approvals by the US Food and Drug
Administration (FDA)
